Kevin C. Tang, Chief Executive Officer, 10% Owner, Chief Financial Officer, Officer at Odonate Therapeutics, Inc. (ODT), bought 551,568 shares at $14.58 ($8.4M) on 2020-12-21, disclosed to the SEC on 2020-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.58 | 62,144 | $906K | 10.8% |
| 2 | $14.58 | 62,144 | $906K | 10.8% |
| 3 | $14.58 | 37,856 | $552K | 6.6% |
| 4 | $14.58 | 37,856 | $552K | 6.6% |
| 5 | $15.17 | 36,646 | $556K | 6.6% |
| 6 | $15.17 | 36,646 |
| $556K |
| 6.6% |
| 7 | $15.43 | 63,354 | $978K | 11.7% |
| 8 | $15.43 | 63,354 | $978K | 11.7% |
| 9 | $15.71 | 75,784 | $1.2M | 14.2% |
| 10 | $15.71 | 75,784 | $1.2M | 14.2% |
| Total | $15.16 avg | 551,568 | $8.4M | 100% |
| Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |
| LJPC | BUY | 2020-01-13 | $34.9M | — | Filing → |